Evidence map›Paper›PMID 18558101›Full record

ReviewBiochimica et biophysica acta2008

Sphingosine-1-phosphate lyase in development and disease: sphingolipid metabolism takes flight.

Henrik Fyrst, Julie D Saba

Open access · greenAbstract readReview
In one paragraph

Review in Biochimica et biophysica acta, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Clinical application of ceramide in cancer treatment.Breast cancer (Tokyo, Japan) · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sphingolipids in mitochondria.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2017
    Review
  16. Review
  17. Article
  18. Regulation of Immune Cell Migration by Sphingosine-1-Phosphate.Cellular and molecular biology (OMICS) · 2015
    Article
  19. Review
  20. Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Henrik FyrstChildren's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA 94609, USA.
Julie D Saba

Funding

S1P Lyase in colon cancerR01CA129438 · NCI · CHILDREN'S HOSPITAL & RES CTR AT OAKLAND · PI SABA, JULIE D · 2007 to 2017
$3.2M
SPHINGOSINE--REGULATION AND POTENTIAL ROLE IN CANCERR01CA077528 · NCI · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 1998 to 2009
$2.8M
Sphingolipid Metabolism in Drosophila DevelopmentR01GM066954 · NIGMS · CHILDREN'S HOSPITAL &RES CTR AT OAKLAND · PI SABA, JULIE D · 2003 to 2013
$2.5M
NCI NIH HHS 2R01CA77528NCI NIH HHS CA129438NCI NIH HHS R01 CA077528NCI NIH HHS R01 CA129438NIGMS NIH HHS 1R01GM66954NIGMS NIH HHS R01 GM066954
6 · The paper itself

Abstract

Sphingosine-1-phosphate lyase (SPL) is a highly conserved enzyme that catalyses the final step of sphingolipid degradation, namely the irreversible cleavage of the carbon chain at positions 2-3 of a long-chain base phosphate (LCBP), thereby yielding a long-chain aldehyde and phosphoethanolamine. LCBPs are potent signaling molecules involved in cell proliferation, survival, migration, cell-cell interactions and cell stress responses. Therefore, tight regulation of LCBP signaling is required for proper cell function, and perturbations of this system can lead to alterations in biological processes including development, reproduction and physiology. SPL is a key enzyme in regulating the intracellular and circulating levels of LCBPs and is, therefore, gaining attention as a putative target for pharmacological intervention. This review provides an overview of our current understanding of SPL structure and function, mechanisms involved in SPL regulation and the role of SPL in development and disease.

Indexed as

DiseaseAldehyde-LyasesAnimalsApoptosisGene Expression Regulation, DevelopmentalHumansSphingosineAldehyde-LyasesSphingosinesphingosine 1-phosphate lyase (aldolase)

Identifiers

PMID18558101
PMCPMC2749932
OpenAlexW2012749999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.